Press Releases Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets Other stock markets 20:50:46 10/05/2024 BST			5-day change	1st Jan Change
0.3755 ^USD	+0.13%		-2.21%	-80.74%

03-28	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
03-28	Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Agile Therapeutics: Q4 Earnings Snapshot	03-28	AQ
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update	03-28	AQ
Agile Therapeutics Announces Delisting from Nasdaq	03-25	AQ
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024	03-21	AQ
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024	03-20	AQ
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution	03-13	AQ
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds	02-22	AQ
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update	02-15	AQ
AGILE THERAPEUTICS - THE BIDEN-HARRIS ADMINISTRATION ANNOUNCES NEW GUIDANCE TO ENABLE EXPANDED ACCESS TO ALL FDA-APPROVED CONTRACEPTIVES WITHOUT COST	01-24	AQ
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost	01-23	AQ
Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement	12-12	AQ
Agile Therapeutics: Q3 Earnings Snapshot	11-09	AQ
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	11-09	AQ
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023	26/10/23	AQ
AGILE THERAPEUTICS REPORTS AN INDUCEMENT GRANT TO NEW CHIEF FINANCIAL OFFICER UNDER NASDAQ LISTING RULE 5635(4)	05/10/23	AQ
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)	04/10/23	AQ
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	05/09/23	AQ
Agile Therapeutics: Q2 Earnings Snapshot	09/08/23	AQ
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update	09/08/23	AQ
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023	26/07/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Press Releases

Filters